| Dementia and COVID-19, a bidirectional liaison: risk factors, biomarkers, and optimal health care S Toniolo, M Scarioni, F Di Lorenzo, J Hort, J Georges, S Tomic, F Nobili, ... Journal of Alzheimer's Disease 82 (3), 883-898, 2021 | 51 | 2021 |
| Is the frontal lobe the primary target of SARS-CoV-2? S Toniolo, F Di Lorenzo, M Scarioni, KS Frederiksen, F Nobili Journal of Alzheimer's Disease 81 (1), 75-81, 2021 | 51 | 2021 |
| The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients AM Pietroboni, L Dell’Arti, M Caprioli, M Scarioni, T Carandini, A Arighi, ... Multiple Sclerosis Journal 25 (1), 31-38, 2019 | 51 | 2019 |
| CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis AM Pietroboni, F Schiano di Cola, M Scarioni, C Fenoglio, B Spanò, ... Multiple Sclerosis Journal 23 (8), 1085-1091, 2017 | 49 | 2017 |
| CSF β-amyloid and white matter damage: a new perspective on Alzheimer’s disease AM Pietroboni, M Scarioni, T Carandini, P Basilico, M Cadioli, G Giulietti, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (4), 352-357, 2018 | 48 | 2018 |
| Frontotemporal dementia: correlations between psychiatric symptoms and pathology M Scarioni, P Gami‐Patel, Y Timar, H Seelaar, JC van Swieten, ... Annals of neurology 87 (6), 950-961, 2020 | 43 | 2020 |
| Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes AM Pietroboni, T Carandini, A Colombi, M Mercurio, L Ghezzi, G Giulietti, ... European Journal of Nuclear Medicine and Molecular Imaging 46, 280-287, 2019 | 40 | 2019 |
| Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes T Carandini, A Arighi, L Sacchi, GG Fumagalli, AM Pietroboni, L Ghezzi, ... Alzheimer's Research & Therapy 11, 1-11, 2019 | 32 | 2019 |
| Cerebrospinal fluid level of aquaporin4: a new window on glymphatic system involvement in neurodegenerative disease? A Arighi, A Di Cristofori, C Fenoglio, S Borsa, M D’Anca, GG Fumagalli, ... Journal of Alzheimer's Disease 69 (3), 663-669, 2019 | 28 | 2019 |
| CSF β-amyloid predicts prognosis in patients with multiple sclerosis AM Pietroboni, M Caprioli, T Carandini, M Scarioni, L Ghezzi, A Arighi, ... Multiple Sclerosis Journal 25 (9), 1223-1231, 2019 | 26 | 2019 |
| Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation L Ghezzi, T Carandini, A Arighi, C Fenoglio, M Arcaro, M De Riz, ... Neurology 89 (24), 2503-2505, 2017 | 26 | 2017 |
| Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel. Dementia and COVID-19, a bidirectional liaison: risk factors, biomarkers, and optimal health care S Toniolo, M Scarioni, F Di Lorenzo, J Hort, J Georges, S Tomic, F Nobili, ... J. Alzheimers Dis 82 (3), 883-98, 2021 | 22 | 2021 |
| Right temporal variant frontotemporal dementia is pathologically heterogeneous: a case-series and a systematic review H Ulugut, AA Dijkstra, M Scarioni, Netherlands Brain Bank, F Barkhof, ... Acta neuropathologica communications 9 (1), 131, 2021 | 21 | 2021 |
| Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease GG Fumagalli, P Basilico, A Arighi, M Mercurio, M Scarioni, T Carandini, ... NeuroImage: Clinical 28, 102453, 2020 | 15 | 2020 |
| The right temporal variant of frontotemporal dementia is not genetically sporadic: a case series H Ulugut Erkoyun, SJ van der Lee, B Nijmeijer, R van Spaendonk, ... Journal of Alzheimer's Disease 79 (3), 1195-1201, 2021 | 14 | 2021 |
| Word and picture version of the free and cued selective reminding test (FCSRT): is there any difference? A Arighi, T Carandini, M Mercurio, G Carpani, AM Pietroboni, G Fumagalli, ... Journal of Alzheimer's Disease 61 (1), 47-52, 2018 | 14 | 2018 |
| PRNP P39L variant is a rare cause of frontotemporal dementia in Italian population E Oldoni, GG Fumagalli, M Serpente, C Fenoglio, M Scarioni, A Arighi, ... Journal of Alzheimer's Disease 50 (2), 353-357, 2016 | 14 | 2016 |
| Psychiatric symptoms of frontotemporal dementia and subcortical (co-) pathology burden: new insights M Scarioni, P Gami-Patel, CFW Peeters, F de Koning, H Seelaar, MO Mol, ... Brain 146 (1), 307-320, 2023 | 10 | 2023 |
| The severity of behavioural symptoms in FTD is linked to the loss of GABRQ‐expressing VENs and pyramidal neurons P Gami‐Patel, M Scarioni, FH Bouwman, BDC Boon, JC van Swieten, ... Neuropathology and applied neurobiology 48 (4), e12798, 2022 | 9 | 2022 |
| Social cognition deficits and biometric signatures in the behavioural variant of Alzheimer’s disease EH Singleton, JLP Fieldhouse, JJ van’t Hooft, M Scarioni, ... Brain 146 (5), 2163-2174, 2023 | 7 | 2023 |
